Visual outcome after posterior uveal melanoma episcleral brachytherapy including radiobiological doses.

Purpose: To assess the long-term influence of radiobiological doses in the evolution of visual acuity (VA) in patients with uveal melanoma treated by episcleral brachytherapy.

Material And Methods: Visual acuity was evaluated prospectively from a case series of 243 patients in 2016 treated with I. Data analysis was applied to trend VA outcome and find the accurate best-fit line.